Blinatumomab-induced catastrophic immune effector cell-associated neurotoxicity with diffuse cerebral edema in a patient with ALL: Case report
Int. Journal of Clinical Pharmacology and Therapeutics · 01.10.2026 · 64 (10) · 548-554
DOI: 10.5414/cp205012 ↗Kurz gefasst
Fallbericht in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.10.2026. Verfasst von Xuemei Guo und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Neurotoxicity Syndromes, Brain Edema, Antibodies, Bispecific, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Guo, X., Wei, Y., Fang, Y., & Lin, R. (2026). Blinatumomab-induced catastrophic immune effector cell-associated neurotoxicity with diffuse cerebral edema in a patient with ALL: Case report. Int. Journal of Clinical Pharmacology and Therapeutics, 64(10), 548-554. https://doi.org/10.5414/cp205012
Vancouver
Guo X, Wei Y, Fang Y, Lin R. Blinatumomab-induced catastrophic immune effector cell-associated neurotoxicity with diffuse cerebral edema in a patient with ALL: Case report. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(10):548-554. doi:10.5414/cp205012
BibTeX
@article{Guo2026,
author = {Guo, Xuemei and Wei, Yuting and Fang, Yongjun and Lin, Rufeng},
title = {Blinatumomab-induced catastrophic immune effector cell-associated neurotoxicity with diffuse cerebral edema in a patient with ALL: Case report},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {10},
pages = {548--554},
doi = {10.5414/cp205012}
}
EUVIMED